Guangyang Weng

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Venues

Cancer medicine

Annals of hematology

Journal of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Guangyang Weng, Jingya Huang, Na An, Yu Zhang, Guopan Yu, Zhiqiang Sun, Dongjun Lin, Lan Deng, Xinquan Liang, Jie Xiao, Hongyu Zhang, Ziwen Guo, Xin He, Hua Jin, Qi-Fa Liu, Xin Du
Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax-based therapy. Cancer medicine 13 (2) (2024)
Guangyang Weng, Jingya Huang, Na An, Yu Zhang, Guopan Yu, Zhiqiang Sun, Dongjun Lin, Lan Deng, Xinquan Liang, Jie Xiao, Hongyu Zhang, Ziwen Guo, Xin He, Hua Jin, Qi-Fa Liu, Xin Du
Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax-based therapy. Cancer medicine 13 (2) (2024)
Guangyang Weng, Jingya Huang, Na An, Yu Zhang, Guopan Yu, Zhiqiang Sun, Dongjun Lin, Lan Deng, Xinquan Liang, Jie Xiao, Hongyu Zhang, Ziwen Guo, Xin He, Hua Jin, Qi-Fa Liu, Xin Du
Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax-based therapy. Cancer medicine 13 (2) (2024)
Guangyang Weng, Jingya Huang, Xin He, Tingting Xue, Linlin Yang, Yu Zhang, Guopan Yu, Zhiqiang Sun, Dongjun Lin, Lan Deng, Xinquan Liang, Jie Xiao, Hongyu Zhang, Ziwen Guo, Hua Jin, Qifa Liu, Xin Du
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study. Annals of hematology (2023)
Guangyang Weng, Yu Zhang, Guopan Yu, Tingyue Luo, Sijian Yu, Na Xu, Zhiqiang Sun, Dongjun Lin, Lan Deng, Xinquan Liang, Jie Xiao, Hongyu Zhang, Ziwen Guo, Ruoyang Shao, Xin Du, Hua Jin, Qifa Liu
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia. Journal of internal medicine (2022)

Guangyang Weng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Guangyang Weng